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Tuberculosis (TB) case fatality rates in sub-Saharan Africa have
been rising due to the burgeoning HIV epidemic.1 Most of the
deaths in HIV-infected patients on TB therapy are due to other
HIV-related diseases.1 The proportion of patients with HIV-
associated TB is higher in hospitals than in TB clinics,2
presumably because they are more ill due to immune
suppression or co-morbidity from other opportunistic
infections. The Western Cape has a high incidence rate of TB
(581/100 000 in 1999), and a rapidly increasing prevalence of
HIV infection. This has resulted in a greater demand for
inpatient TB treatment, with lengthening waiting lists for beds
in TB hospitals. 
As a result of the reduced diagnostic yield from sputum
smears in HIV-infected patients, especially inpatients,3 many
are commenced on empirical antituberculosis treatment. A
proportion of these bacteriologically unconfirmed cases are
managed in the TB hospitals because of a poor general state of
health. Co-morbidity from other opportunistic infections is
frequent in these patients, resulting in increased mortality and
a disease burden on TB hospitals, for which they are ill
equipped. This study assesses the impact of HIV on the 305-
bed TB hospital, Brooklyn Chest Hospital (BCH), Cape Town.
We attempt to come up with recommendations to ease the
pressure on the limited number of beds available for inpatient
TB treatment.
Methods
Admissions, deaths and HIV status were obtained from the
BCH register from 1998 to 2001 to assess trends over time. A
detailed retrospective review of records of all adult admissions
(individuals aged 13 years and above) from February through
July 2000 was undertaken in order to establish the number of
patients with known HIV serostatus, type of TB, diagnosis of
TB and predictors of death. We defined TB as culture of
Mycobacterium tuberculosis or smear-positive for acid-fast bacilli
or typical cerebrospinal fluid findings of TB meningitis (in this
latter category we excluded HIV-seropositive individuals in
view of the large number of potential causes of cerebrospinal
fluid pleocytosis in these patients). Patients with TB not
fulfilling these definitions were categorised as unconfirmed.
Results
The number of admissions, deaths and patients known to have
HIV infection is shown in Table I. There was a significant
increase in the proportion of deaths (15% in 1998 to 25% in
2001, c 2 for trend p = 0.008) and the proportion known to be
HIV-infected (18% in 1998 to 35% in 2001, p < 0.001) from 1998
to 2001. The proportion of deaths in the sub-group known to be
HIV-infected did not change over time (p = 0.14). In the
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Mortality and HIV prevalence rose concordantly at Brooklyn
Chest Hospital from 1998 to 2001. Death and unconfirmed
tuberculosis (TB) (15% of adult admissions in a sample from
2000) were associated with HIV seropositivity. Excluding
unconfirmed TB and shortening length of stay would
increase the number of patients able to benefit from
hospitalisation.
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Table I. Admissions, HIV status (passive surveillance) and deaths
at Brooklyn Chest Hospital 1998 - 2001 (numbers in parentheses
are % of total admissions).
1998 1999 2000 2001
Admissions 1 178 1 286 1 143 1 117
Deaths 180 (15) 212 (16) 199 (17) 280 (25)
HIV-positive 
admissions 210 (18) 320 (25) 278 (24) 393 (35)
H I V-positive deaths 77 92 89 141
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detailed record review from February to July 2000, 434 adults
were admitted (mean age 37 years, range 13 - 86 years, 60%
males). HIV serostatus was recorded in 58%, of whom 71%
were seropositive. 
TB was pulmonary (presumed drug-sensitive) in 66%,
pulmonary confirmed multidrug-resistant in 16%,
extrapulmonary in 3% and unconfirmed in 15%. In patients
with known HIV serostatus unconfirmed TB occurred in 5% of
HIV-seronegative compared with 24% of HIV-seropositive
patients (p < 0.001). Treatment of patients with unconfirmed TB
accounted for 2 888 hospital-bed days. HIV-infected patients
had an increased mortality compared with those who were
HIV-seronegative (relative risk 2.2, 95% confidence intervals
(CI): 1.2 - 4.1, p = 0.014). HIV infection accounted for 55 excess
deaths (34% of all deaths).  The mean length of stay was 94
days (range 2 - 314 days); this was shorter for HIV- seropositive
than HIV-seronegative patients (89 versus 110 days, p < 0.01).
The shorter stay of HIV-seropositive patients was not explained
by increased mortality. Length of stay was not significantly
different for patients with confirmed or unconfirmed TB (96
versus 83 days, p = 0.18). Sixty-three per cent of patients stayed
more than 2 months and 13% were hospitalised for more than 6
months.
Discussion
This study is limited as it is retrospective and HIV serostatus
was only determined in 58% of adult admissions. Nevertheless
it is clear that there has been an increased death rate, which is
almost certainly due to an increase in HIV-seropositive
admissions. A substantial proportion of HIV-infected patients
had no bacteriological confirmation of their TB. Arguably,
unconfirmed cases should not be admitted to a TB hospital. As
these patients are not highly infectious, and some may not
have TB at all, it does not seem appropriate to admit them to a
TB hospital where they run the risk of acquiring multidrug-
resistant TB.4 Patients with unconfirmed TB who are too ill for
ambulatory treatment could be cared for by home-based care
organisations. Restricting adult admissions to patients with a
diagnosis of confirmed pulmonary TB or TB meningitis would
allow the treatment of an extra 110 cases per annum. 
The mean length of stay was shorter for HIV-infected
patients. Patients with multidrug resistance and meningitis
generally have prolonged admissions. It is our view that by
adopting a more aggressive discharge policy it should be
possible to reduce the mean length of stay to 2 months. If this
could be achieved our data indicate that a further 263 patients
a year could have received inpatient treatment. 
In conclusion, restricting adult admissions to patients with
confirmed TB and reducing mean length of stay to 2 months
would considerably ease the pressure on TB hospital beds and
shorten waiting lists. 
We thank the superintendent of BCH, Dr Peter Morris, for
allowing access to patient charts and for his helpful comments.
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